DZ Bank’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-15,781
Closed -$725K – 1017
2022
Q1
$725K Sell
15,781
-26,140
-62% -$1.25M ﹤0.01% 765
2021
Q4
$2.6M Buy
41,921
+25,137
+150% +$1.74M ﹤0.01% 694
2021
Q3
$1.25M Sell
16,784
-41
-0.2% -$3.44K ﹤0.01% 662
2021
Q2
$1.56M Buy
16,825
+16,191
+2,554% +$1.38M ﹤0.01% 636
2021
Q1
$56.3K Buy
+634
New +$62.9K ﹤0.01% 866

Other funds holding ARKG

DZ Bank's ARKG Position: Q2 2022 in Review

DZ Bank sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 15,781 shares — an estimated $725K sold.

DZ Bank first reported a position in ARKG in Q1 2021 and held it in 5 quarters. The position peaked at $2.6M in Q4 2021. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • DZ Bank reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • DZ Bank sold 15,781 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $725K.
  • DZ Bank first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 5 quarters.
  • DZ Bank's ARK Genomic Revolution ETF position peaked at $2.6M in Q4 2021.
  • 334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on DZ Bank's 13F filing for Q2 2022, filed 15 Aug 2022.